Evidence map›Paper›PMID 38272706›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2024

Imaging of Tumor Stroma Using

Bingxin Gu, Ziyi Yang, Xinyue Du, Xiaoping Xu, Xiaomin Ou, Zuguang Xia, Qing Guan, Silong Hu, Zhongyi Yang, Shaoli Song

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Prognostic value and diagnostic performance of nectin-4-targeted [European journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Diagnostic value of [Abdominal radiology (New York) · 2026
    Article
  4. Review
  5. Superiority of [Annals of surgical oncology · 2026
    Article
  6. European journal of nuclear medicine and molecular imaging · 2026
    Article
  7. Comparative Insights intoMolecular imaging and radionuclide therapy · 2026
    Article
  8. Review
  9. Prospective Head-to-Head Comparison ofRadiology. Imaging cancer · 2026
    Article
  10. [European journal of nuclear medicine and molecular imaging · 2026
    Article
  11. cGMP-compliant high-yield automated production of [EJNMMI radiopharmacy and chemistry · 2025
    Article
  12. Review
  13. Review
  14. Review
  15. Head-to-head comparison of [European journal of nuclear medicine and molecular imaging · 2025
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Bingxin GuDepartment of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Ziyi YangDepartment of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Xinyue DuDepartment of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Xiaoping XuDepartment of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Xiaomin OuDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Zuguang XiaDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; and.
Qing GuanDepartment of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Silong HuDepartment of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhongyi YangDepartment of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China; shaoli-song@163.com yangzhongyi21@163.com.
Shaoli SongDepartment of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China; shaoli-song@163.com yangzhongyi21@163.com.
Fudan University · CNFudan University Shanghai Cancer Center · CNShanghai Medical College of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The low detection rate of primary tumors by current diagnostic techniques remains a major concern for patients with head and neck cancer of unknown primary (HNCUP). Therefore, in this study, we aimed to investigate the potential role of

Indexed as

Head and Neck NeoplasmsNeoplasms, Unknown PrimaryAdultAgedChinaFemaleFluorodeoxyglucose F18Gallium RadioisotopesHumansMaleMiddle AgedPositron-Emission TomographyPositron Emission Tomography Computed TomographyProspective StudiesYoung AdultFluorodeoxyglucose F18Gallium Radioisotopescancer of unknown primaryFDGfibroblast activation proteinhead and neck cancerPET/CT

Identifiers

PMID38272706
PMCPMC10924163
OpenAlexW4391216919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.